Clinical and Practical Psychopharmacology

Clinical and Practical Psychopharmacology

The Primary Outcome Measure and Its Importance in Clinical Trials

October 21, 2015

Clinical and Practical Psychopharmacology

Bioequivalence of Generic Drugs

September 23, 2015

Clinical and Practical Psychopharmacology

Sustained-Release, Extended-Release, and Other Time-Release Formulations in Neuropsychiatry

August 26, 2015

Clinical and Practical Psychopharmacology

Understanding Relative Risk, Odds Ratio, and Related Terms: As Simple as It Can Get

July 22, 2015

Clinical and Practical Psychopharmacology

Bioequivalence of Generic Drugs: A Simple Explanation for a US Food and Drug Administration Requirement

June 24, 2015

Clinical and Practical Psychopharmacology

Intranasal Drug Delivery in Neuropsychiatry: Focus on Intranasal Ketamine for Refractory Depression

May 27, 2015

Clinical and Practical Psychopharmacology

Cost of Treatment as a Placebo Effect in Psychopharmacology: Importance in the Context of Generic Drugs

April 22, 2015

Clinical and Practical Psychopharmacology

The Numbers Needed to Treat and Harm (NNT, NNH) Statistics: What They Tell Us and What They Do Not

March 25, 2015

Clinical and Practical Psychopharmacology

A Primer on Confidence Intervals in Psychopharmacology

February 25, 2015

Clinical and Practical Psychopharmacology

Serotonin Reuptake Inhibitors and ODD

January 28, 2015

Read about Ondansetron Augmentation of Serotonin Reuptake Inhibitors and how they can be used as a Treatment Strategy in Obsessive-Compulsive Disorder (OCD).

Clinical and Practical Psychopharmacology

The Safety of Duloxetine During Pregnancy and Lactation

December 24, 2014

Clinical and Practical Psychopharmacology

Fruit Juice, Organic Anion Transporting Polypeptides, and Drug Interactions in Psychiatry

November 24, 2014